New York City-based One Drop has acquired all the assets and intellectual property of Sano Intelligence, Inc., including its continuous glucose sensing platform.
One Drop is a digital health company focused on eHealth solutions for people living with diabetes and other chronic conditions. It offers a diabetes management platform with affordable and accessible care to patients via an iOS or Android smartphone. The app is available for free download worldwide.
Sano Intelligence, a Silicon Valley healthcare startup, has developed a biometric sensor that can capture and transmit glucose and blood chemistry data continuously to any device.
The almost decade of work put into developing the Sano continuous glucose sensing platform will live on in a comprehensive solution from One Drop. The planned development marks a significant milestone in its effort to bring personalized, adaptive health solutions to people in real-time via their mobile phones.
One Drop will leverage the acquired assets, including silicon-sensing production infrastructure, to design, produce, and commercialize a painless, silicon-based continuous health sensing platform for use across multiple conditions.
To date, One Drop has collected 9 billion longitudinal health data points across 75 biomarkers from nearly 2.5 million users. The company’s continuous health sensing platform will add thousands of new data points per user per day, strengthening the machine learning models behind its predictive and adaptive support capabilities across multiple conditions.
Financial terms were not disclosed. The deal was structured as an asset purchase, and several Sano team members will join One Drop.
It’s been a while since significant diabetes deals were announced. Going back to 2018, Johnson & Johnson (NYSE: JNJ) paid $2.1 billion for LifeScan‘s glucose blood monitoring system. LifeScan’s products were used by approximately 20 million patients globally in more than 90 countries. Back in 2015, Bayer AG (XETRA: BAYN) sold its Diabetes Care business to Panasonic Healthcare Holdings Co., Ltd. for $1.154 billion. Now Bayer is backing One Drop, along with RRE Ventures, Launch Fund, and FJ Labs.
